Taken together, these data indicate a critical tumor suppressive role of the FLCN complex in BHD-associated renal cancer proliferation and tumorigenesis, and β-TRCP counteracts the observed tumor suppressive function through FNIP degradation. The gene discussed is BTRC; the disease is renal carcinoma.